Suppr超能文献

脑水肿发病机制中的病理学及新因素

Pathology and new players in the pathogenesis of brain edema.

作者信息

Nag Sukriti, Manias Janet L, Stewart Duncan J

机构信息

Department of Laboratory Medicine and Pathobiology, Banting Institute, University of Toronto, Rm 417, 100 College Street, Toronto, ON M5G1L5, Canada.

出版信息

Acta Neuropathol. 2009 Aug;118(2):197-217. doi: 10.1007/s00401-009-0541-0. Epub 2009 Apr 30.

Abstract

Brain edema continues to be a major cause of mortality after diverse types of brain pathologies such as major cerebral infarcts, hemorrhages, trauma, infections and tumors. The classification of edema into vasogenic, cytotoxic, hydrocephalic and osmotic has stood the test of time although it is recognized that in most clinical situations there is a combination of different types of edema during the course of the disease. Basic information about the types of edema is provided for better understanding of the expression pattern of some of the newer molecules implicated in the pathogenesis of brain edema. These molecules include the aquaporins, matrix metalloproteinases and growth factors such as vascular endothelial growth factors A and B and the angiopoietins. The potential of these agents in the treatment of edema is discussed. Since many molecules are involved in the pathogenesis of brain edema, effective treatment cannot be achieved by a single agent but will require the administration of a "magic bullet" containing a variety of agents released at different times during the course of edema in order to be successful.

摘要

脑水肿仍然是多种脑部病变(如大面积脑梗死、出血、创伤、感染和肿瘤)后死亡的主要原因。尽管人们认识到在大多数临床情况下,疾病过程中会出现不同类型水肿的组合,但将水肿分为血管源性、细胞毒性、脑积水性和渗透性水肿的分类方法经受住了时间的考验。本文提供了有关水肿类型的基本信息,以便更好地理解一些与脑水肿发病机制相关的新型分子的表达模式。这些分子包括水通道蛋白、基质金属蛋白酶以及血管内皮生长因子A和B、血管生成素等生长因子。本文还讨论了这些药物在治疗水肿方面的潜力。由于许多分子参与了脑水肿的发病机制,单一药物无法实现有效治疗,而需要使用一种“神奇子弹”,即包含多种在水肿过程中不同时间释放的药物,才能取得成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验